Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2017

Open Access 01-12-2017 | Letter

High body mass index in rheumatoid arthritis: why we should promote physical activity

Authors: M. Hugo, N. Mehsen-Cetre, A. Pierreisnard, E. Pupier, B. Cherifi, T. Schaeverbeke, V. Rigalleau

Published in: Arthritis Research & Therapy | Issue 1/2017

Login to get access

Excerpt

We were interested in the recent publication of Albrecht et al. on body mass index (BMI) distribution in rheumatoid arthritis (RA) [1]. According to this analysis of three large cohorts, the majority of patients with RA are overweight [1]. Low remission rates and common metabolic syndrome indicate that the increasing BMI in RA should be treated, but weight loss may not be the solution as it has been linked to increased mortality [2]. Working on nutritional status in RA, we had the opportunity to compare the body composition analysis (DEXA) and physical activity levels recorded over 3 days with Actimeters (SenseWear Arm Bands, Body Media, Stanford, CA, USA) in overweight versus normal-weight patients. We feel that our results may help orientate management despite the obesity paradox in RA. …
Literature
1.
go back to reference Albrecht K, Richter A, Callhoff J, Huscher D, Schett G, Strangfeld A, Zink A. Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases. Arthritis Res Ther. 2016;23(18):149. doi:10.1186/s13075-016-1043-9. Albrecht K, Richter A, Callhoff J, Huscher D, Schett G, Strangfeld A, Zink A. Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases. Arthritis Res Ther. 2016;23(18):149. doi:10.​1186/​s13075-016-1043-9.
2.
go back to reference Baker JF, Billig E, Michaud K, Ibrahim S, Caplan L, Cannon GW, et al. Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis. Arthritis Rheumatol. 2015;67(7):1711–7.CrossRefPubMedPubMedCentral Baker JF, Billig E, Michaud K, Ibrahim S, Caplan L, Cannon GW, et al. Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis. Arthritis Rheumatol. 2015;67(7):1711–7.CrossRefPubMedPubMedCentral
3.
go back to reference van Staa TP, Geusens P, Bijlsma JW, et al. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(10):3104–12.CrossRefPubMed van Staa TP, Geusens P, Bijlsma JW, et al. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(10):3104–12.CrossRefPubMed
4.
go back to reference Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Panoulas VF, Douglas KMJ, Jamurtas AZ, et al. What predicts obesity in patients with rheumatoid arthritis ? An investigation of the interactions between lifestyle and inflammation. Int J Obesity. 2010;34:295–301.CrossRef Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Panoulas VF, Douglas KMJ, Jamurtas AZ, et al. What predicts obesity in patients with rheumatoid arthritis ? An investigation of the interactions between lifestyle and inflammation. Int J Obesity. 2010;34:295–301.CrossRef
5.
go back to reference Cai X, Qiu SH, Yin H, Sun ZL, Ju CP, Zügel M, et al. Pedometer intervention and weight loss in overweight and obese adults with type 2 diabetes: a meta-analysis. Diabet Med. 2016;33(8):1035–44.CrossRefPubMedPubMedCentral Cai X, Qiu SH, Yin H, Sun ZL, Ju CP, Zügel M, et al. Pedometer intervention and weight loss in overweight and obese adults with type 2 diabetes: a meta-analysis. Diabet Med. 2016;33(8):1035–44.CrossRefPubMedPubMedCentral
Metadata
Title
High body mass index in rheumatoid arthritis: why we should promote physical activity
Authors
M. Hugo
N. Mehsen-Cetre
A. Pierreisnard
E. Pupier
B. Cherifi
T. Schaeverbeke
V. Rigalleau
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2017
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-016-1209-5

Other articles of this Issue 1/2017

Arthritis Research & Therapy 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.